Introduction
Extracellular vesicles (EVs), which are most prominently involved in shuttling reciprocal signals between myelinating glia and neurons, contribute to many aspects of central nervous system (CNS) development and function, including regulation of synaptic communication, synaptic strength, and synapse assembly and plasticity (1-3).
EVs can selectively shuttle cytosolic and membrane proteins, as well as RNA and lipids, across cells to achieve an exchange of signaling molecules (4, 5). and leucine-rich repeat serine/threonine kinase 2 (LRRK2) (22, 23) . Some of these proteins are considered to be potential biomarkers for neurodegenerative diseases such as Alzheimer disease (AD), Parkinson disease and amyotrophic lateral sclerosis (ALS). For example, alpha-synuclein, which is packaged into EVs for extracellular transport and released into extracellular space, has been closely linked to the pathogenesis of PD (16). Additional evidence suggests that EVs play a role in the sequestration of toxic oligomers and in the release of oligomers from protein aggregates (24) (25) (26) . The loss of functional aggregated proteins can interference with axonal transport and lead to proteasomal inhibition, synaptic toxicity and endoplasmic reticulum stress (27) (28) (29) (30) (31) (32) . Parkinson's disease patients showed increase of cyclic GMP in the GPi instead of increasing of extracellular glutamate (55). The basal forebrain (BF) is considered to be a major cholinergic hub of the central nervous system. It consists of several structures that send cholinergic projections to the cortex, hippocampus and other brain regions where they play an important role in various cognitive functions including learning, memory, formation and attention. The
Nucleus basalis magnocellularis (NBM) is part of this structure, projecting mainly to the neocortex, amygdala, and thalamus (56, 57) . Previous studies showed that the NBM has important role in the neural activity in learning and memory (58) (59) (60) (61) (62) , such that for example NBM lesions affect the acquisition of spatial memory and produce a severe selective disturbance in recent memories (63, 64) and electrical NBM stimulation improves cognitive functions of patients suffering from dementia (65).
Effects of NBM electrical stimulation have been demonstrated also at the level of neural activation patterns in cortex, such that for example BF activation robustly enhances contrast sensitivity in visual cortex (VC), an effect that likely involves cholinergic modulation but also BF GABAergic projections to VC (66). The effects of DBS at the level of physiological signaling cascades has been much less investigated.
Here we hypothesize that BF simulation may also exert a profound influence on signaling pathways within the BF and at BF projection brain regions. We employed differential centrifugations for isolation of EVs from PFC, hippocampus and striatum brain regions after unilateral electrical stimulation in the NBM of the rat brain, with the other non-stimulated brain hemisphere serving as control. Such an internal control allows us to reduce data variability across animals and improves the accuracy of results. In addition, we employed the dimethyl label method for relative quantification on levels of proteins and peptides. We observed a large number of significantly modulated proteins in brain regions of the stimulated hemisphere compared with the control hemisphere. Using functional analysis with the DAVID algorithm, we linked these identified EV-proteins to oxidative stress, DNA damage, nervous system development and signaling processes.
EXPERIMENTAL SECTION Materials
LC-MS grade acetonitrile and formic acid were purchased from Fisher and Fluka, respectively. Acetic acid was purchased from Fluka (Buchs, Switzerland). Pure water was prepared by GenPure system (TKA, Niederelbert, Germany). Siliconized micro centrifuge tubes were purchased from Eppendorf (Hamburg, Germany).
Formaldehyde (CH 2 O, 37%, v/v, cat. no. 252549) , sodium cyanoborohydride (NaBH 3 CN, cat. no. 156159) and triethylammonium bicarbonate buffer (TEAB, cat.
No. T7408) were purchased from Sigma. Sodium cyanoborohydride (NaBD 3 CN, 96% 
DBS animals
DBS is known to have an excitatory or inhibitory effect depending on stimulation frequency stimulation, although results tend to vary as a function of stimulation parameters and brain region under study (67) (68) (69) , and biphasic cathode-first stimulation tends to be more effective in eliciting functional responses (70) (71) (72) . In the present study, we tested different stimulation parameter combinations and selected biphasic pulse trains with 20 Hz frequency, ±8 V amplitude, 100µs pulse duration, 500 ms pulse train duration and 10s pulse trains intervals. This stimulation protocol was applied during two consecutive days with three stimulation sessions per day lasting 1h each with a 1h pause between sessions. BF electrodes were implanted bilaterally, but only one hemisphere was stimulated in each animal with the other hemisphere serving as a control. A total of n=6 animals were used in this study.
EVs Isolation and Sample Preparation
The EVs isolation protocol was modified according to a previous report (73). In order to obtain enough analyte for the procedures, samples from two animals were pooled together as one biological replicate. 
Data analysis and Statistics
All the raw MS data files were processed on MaxQuant software (version 1.6.1.0) (76) for proteins and peptides identification and quantification, and trypsin was specified as digestion for Uniprot rat database (January 2017) searching with a false discovery rate (FDR)<0.01 at level of proteins, peptides, and modifications. DimethLys0 and DimethNter0 were specified as "Light Labels"; DimethLys8 and DimethNter8 were specific as "Heavy Labels", and 3 maximum labeling for each peptide. Acetylation (protein N-term), phosphorylation (S/T/Y), and oxidation on methionine were selected for the variable PTMs with 3 maximum modifications for each peptide, and carbamidomethyl as fixed modification. The minimum peptide length is seven amino acids, and "match between runs" enabled with a matching time window of 1 min.
Proteins and peptides were identified using the Andromeda search engine integrated into the MaxQuant environment (77). Bioinformatics analysis was performed on Perseus(78) and significant A with p-value (FDR 0.05) was used for proteins significantly analysis. A site localization probability of 0.75 was used as cutoff for localization of phosphopeptides sites. The phosphorylation motifs were determined by pLogo program (79). The proteins network was analyzed with STRING(80) and visualized by Cytoscape (81). We used Perseus significance A (78) to determine differential expression of EV proteins in the PFC, hippocampus and striatum of stimulated samples compared with controls.
Results
EVs, including microvesicles and exosomes, were isolated from rat brain tissue PFC, hippocampus and striatum regions with differential high speed centrifugations and ultrahigh speed centrifugations after incubation with papain and series filtration steps (see methods, Figure 1 and Figure S1 ) (82). TEM was employed to confirm that excellent EV purity was achieved using this procedure ( Figure 1C ). After lysis of EVs, dimethyl reagents were used for peptide level stable isotope labeling (83), and mixed peptides were desalted with StageTips (75) and analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) on a high-speed, high-resolution mass spectrometer.
Our strategy allowed us to identify 1037, 634 and 713 EV proteins from PFC, hippocampus and striatum brain regions, which were derived from 1292, 744 and 861 genes, respectively. Gene ontology analysis of the identified EVs proteins indicated overall similar cellular components and biological functions in PFC, hippocampus and striatum (Figure 2A and 2B) . In Figure 2C , we illustrate the gene overlap of identified EV proteins from PFC, hippocampus and striatum. Note that the identification ratio tended to be higher for the PFC compared to the other two regions;
an effect we attribute to the relatively large tissue sample for PFC. Common EV biomarkers were identified in different brain regions ( Figure 2D ), such that the EV marker proteins CD9, CD81, CD82 and HSC70 were in fact present in all three brain areas (PFC, hippocampus and striatum), emphasizing the high purity of our EV isolation procedure from tissue samples. Figure S2 -5. We observe that the hippocampus exhibits less phosphopeptides identification than other regions, and pY EVs are more common in PFC than hippocampus or striatum. In addition, the hippocampal pT site proportion was significantly increased compared to the other regions. The complete list of identified phosphopeptides were shown at Supporting Information Table S2 . All of these disparities may bear relevance to differential brain regions in pathological processes.
To better understand the biological roles of differentially expressed EV proteins, we examined the relationship between EV proteins and specific CNS related diseases, using STRING to identify enriched gene ontology categories and signaling networks.
In PFC, these significant changed proteins were classified into protein biosynthetic process, oxidative stress, signaling, cytoskeleton and nervous system development processes. For the hippocampus, DNA damage, oxidative stress/nervous system development and signaling related EVs proteins were found to be significantly Figure 5B and 5C. These data support the idea that the EVs proteome is a sensitive indicator for physiological regulation and that quantitative analysis of EVs proteome can be disease specific.
Besides, alpha-internexin was also found significantly downregulated average -3.9 times (-1.2 ~ -7.9) in the EVs of the PFC brain region. Other CNS related diseases have also been linked to modulations of neurofilament proteins such as Schizophrenia (87), MDD (88) and suicide (86). We can conclude from the present study that EV associated NF proteins exhibit brain region specific regulation, and EV monitoring may thus provide a more sensitive opportunity to study the pathogenesis of related brain disorders.
We document that in all three brain regions, oxidative stress related proteins were and in transgenic mouse models show that SOD1 is secreted via the microvesilcular secretory pathway(108-110). In our study, SOD1 was significant decreased average -2.3 times (-1.6 ~ -3.0) in stimulated PFC EVs related to control, demonstrating a strong association between DBS and CNS related diseases although the precise mechanism remains unclear. DNA damage process related proteins were also found frequently in our study through the functional analysis. Particularly, mitochondria dysfunction could be linked with sustained oxidative stress in neurodegenerative disorders, which would be have strongly relevant with DNA damage process.
Conclusions
Brain stimulation profoundly impacts the regulation and transmission of signaling molecules in different brain regions. Here, we evaluate DBS effects on brain regions by MS-based EVs proteins quantitative analysis. Last, we got an amount of significant changed EVs proteins in PFC, hippocampus and striatum after stimulation on rat brain BF position. Through functional analysis, these proteins were involved in oxidative stress, nervous system development, DNA damage and protein biosynthetic processes, and some of them are strongly associated with CNS related disorders.
Particularly, the NF proteins that were reported as potential biomarkers in many CNS related diseases. In our study, the NF subunits NFL and NFM were both significantly changed in EVs of PFC, hippocampus and striatum in stimulated samples compared with control. The strongly related to neurodegenerative disease SOD1 protein was also found significantly changed in PFC. All of this founding shown that the brain BF stimulation can impact the EVs proteins differential expression in different regions, which would be helping to explain the stimulation certainly potential effects on benefits of patients in the future. , D e w a n g a n , S . , 
